Sheridan Capital Partners Announces Director of Business Development and Vice President Hires


CHICAGO, IL, July 9, 2018 – Sheridan Capital Partners (“SCP”), a Chicago-based lower middle market private equity firm, announced today that Alexandra Kier and Alexander Kain have joined the firm as Director of Business Development and Vice President, respectively. Alexandra will lead business development for the firm, and Alexander will focus on sourcing and managing investments in the healthcare sector.

Prior to joining Sheridan, Alexandra worked at New Harbor Capital, a private equity firm based in Chicago focused on healthcare, education, and business services. Prior to New Harbor Capital, Alexandra worked at at a venture-backed start-up and Aurora Investment Management in a business development capacity. She started her career at Goldman Sachs in New York. Alexandra earned a Bachelor of Business Administration (BBA) Degree in Finance at The University of Texas at Austin - The Red McCombs School of Business and a MBA from Northwestern University - Kellogg School of Management.

Prior to joining Sheridan, Alexander worked at Cressey & Company, a leading private equity firm who have invested and managed over $1 billion of healthcare investments. Prior to Cressey & Company, Alex worked at Lazard Frères & Co, where he worked in their Investment Banking group. Alex earned a Bachelor’s Degree in Finance at Indiana University – Kelley School of Business and a MBA in Health Care Management / Entrepreneurial Management from The Wharton School of the University of Pennsylvania.

About Sheridan Capital Partners

Sheridan Capital Partners (“SCP”) is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. SCP partners with companies that have enterprise values from $25 million to $150 million, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.

For additional information or inquiries, please contact:


Back to News